# Topical Piroxicam vs Soulagel in the Treatment of Acute Extremity Pain After Emergency Department Discharge

> **NCT05054023** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Monastir** · enrollment: 1525 (actual)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** Soulagel®
- **DRUG:** Arthrosyl®

## Key facts

- **NCT ID:** NCT05054023
- **Lead sponsor:** University of Monastir
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-21
- **Primary completion:** 2022-03-21
- **Final completion:** 2022-03-21
- **Target enrollment:** 1525 (ACTUAL)
- **Last updated:** 2022-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05054023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05054023, "Topical Piroxicam vs Soulagel in the Treatment of Acute Extremity Pain After Emergency Department Discharge". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT05054023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*